The present invention relates to the nanocapsules lipids are especially intended to be administered by injection, for example in the context of a protocol of gene therapy, in particular in a strategy of inhibiting gene. It relates more particularly of the nanocapsules lipid comprising ribonucleic acid, as well as a pharmaceutical composition comprising, a process for their preparation and their uses.